Detection of Microorganisms and Antibiotic Resistance Genes Using the Curetis Unyvero LRT55 Application

CompletedOBSERVATIONAL
Enrollment

2,124

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Pneumonia
Interventions
DEVICE

LRT55 Testing

Testing on the Unyvero LRT55

Trial Locations (9)

10032

Columbia Universiy Medical Center / New York-Presbyterian Hosp., New York

14642

Rochester Medical Center, Rochester

21287

Johns Hopkins Hospital, Baltimore

44304

Summa Health System, Akron

48073

William Beaumont Hospital, Royal Oak

55901

Mayo Clinic, Rochester

60611

Northwestern Memorial Hospital, Chicago

90049

University of California Los Angeles (UCLA), Los Angeles

98195

University of Washington, Seattle

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Global BioClinical

INDUSTRY

lead

Curetis GmbH

INDUSTRY

NCT01922024 - Detection of Microorganisms and Antibiotic Resistance Genes Using the Curetis Unyvero LRT55 Application | Biotech Hunter | Biotech Hunter